Evaluating Post-Mastectomy Chestwall

Status: open

[526659-9] A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant ChemotherapyWho Convert to Pathologically Nega

Treatment for Breast Cancer

Contact Us Or call (251) 445-9834


This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating patients with breast cancer. IRB Number 13-247


This trial is sponsored by NSABP.

Providers Associated With This Trial

Principle Investigator

  • Elesyia OutlawView Profile
    Elesyia D. Outlaw, M.D.Radiation OncologistDirector of Women's Radiotherapy Program; Program Director of Brachytherapy Program; Associate Professor of Interdisciplinary Clinical Oncology

Sub Investigators

This link will open in a new tab or window.